SPHK1 and diabetic cardiomyopathy: Our study showed that the S1P-SphK1 pathway is one of the prominent role players of diabetic cardiac fibrosis; thus, suppressing the SphK1 gene expression can be considered a potential means to prevent diabetic cardiomyopathy.